SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-17-031896
Filing Date
2017-05-11
Accepted
2017-05-11 16:06:30
Documents
57
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a17-8878_110q.htm 10-Q 849746
2 EX-31.1 a17-8878_1ex31d1.htm EX-31.1 12280
3 EX-31.2 a17-8878_1ex31d2.htm EX-31.2 12285
4 EX-32.1 a17-8878_1ex32d1.htm EX-32.1 6813
  Complete submission text file 0001104659-17-031896.txt   3714646

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT catb-20170331.xml EX-101.INS 676065
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT catb-20170331.xsd EX-101.SCH 32213
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT catb-20170331_cal.xml EX-101.CAL 39587
8 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT catb-20170331_lab.xml EX-101.LAB 326073
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT catb-20170331_pre.xml EX-101.PRE 237944
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT catb-20170331_def.xml EX-101.DEF 117939
Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Filer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37467 | Film No.: 17834295
SIC: 2834 Pharmaceutical Preparations